What We're Reading: Page 27
Industry reads hand-picked by our editors
Jun 25, 2025
-
Endpoints News
FDA’s Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say
-
CNN
Presentation for CDC advisers appears to cite nonexistent study to support claims about risk of vaccine preservative
-
Stat News
Top FDA drug regulator tells staff much is still in flux, as she prepares to retire
-
Fierce Biotech
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge research labs
Jun 24, 2025
Jun 23, 2025
Jun 20, 2025
Jun 18, 2025
Jun 17, 2025
Jun 16, 2025
-
Fierce Biotech
The trouble with TIGITs: How ‘overenthusiasm’ led to Big Pharma’s risky $6B gamble
-
Axios
NIH chief sidesteps controversy while other officials court it
-
NPR
The doctor said ‘be happy.’ Music therapy can help cancer patients do that
-
Bloomberg
China’s Biotech Moment Ignites a 60% Stock Rally That Beats AI